Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Friedman

Showing results (371-380 of 380) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 380 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2022
High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial CancerCharles W Ashley, Pier Selenica, Juber Patel, et al.
European Heart Journal|January 22, 2026
Foundation models for electrocardiogram interpretation: clinical implicationsAlexis Nolin-Lapalme, Achille Sowa, Jacques Delfrate, et al.
Nature|May 20, 2020
Anti-PfGARP activates programmed cell death of parasites and reduces severe malariaDipak K Raj, Alok Das Mohapatra, Anup Jnawali, et al.
Nature Genetics|November 27, 2021
Deep learning enables genetic analysis of the human thoracic aortaJames P Pirruccello, Mark D Chaffin, Elizabeth L Chou, et al.
Journal of the National Cancer Institute|February 6, 2023
Comprehensive analysis of germline drivers in endometrial cancerSushmita Gordhandas, Eric Rios-Doria, Karen A Cadoo, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|July 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|December 14, 2022
Ovarian cancer mutational processes drive site-specific immune evasionIgnacio Vázquez-García, Florian Uhlitz, Nicholas Ceglia, et al.
Nature Medicine|January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Cancer Cell|March 27, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Pageof 38

Showing results (371-380 of 380) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 380 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2022
High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial CancerCharles W Ashley, Pier Selenica, Juber Patel, et al.
European Heart Journal|January 22, 2026
Foundation models for electrocardiogram interpretation: clinical implicationsAlexis Nolin-Lapalme, Achille Sowa, Jacques Delfrate, et al.
Nature|May 20, 2020
Anti-PfGARP activates programmed cell death of parasites and reduces severe malariaDipak K Raj, Alok Das Mohapatra, Anup Jnawali, et al.
Nature Genetics|November 27, 2021
Deep learning enables genetic analysis of the human thoracic aortaJames P Pirruccello, Mark D Chaffin, Elizabeth L Chou, et al.
Journal of the National Cancer Institute|February 6, 2023
Comprehensive analysis of germline drivers in endometrial cancerSushmita Gordhandas, Eric Rios-Doria, Karen A Cadoo, et al.
Biorxiv : the Preprint Server for Biology|July 29, 2024
Ongoing genome doubling promotes evolvability and immune dysregulation in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|July 16, 2025
Ongoing genome doubling shapes evolvability and immunity in ovarian cancerAndrew McPherson, Ignacio Vázquez-García, Matthew A Myers, et al.
Nature|December 14, 2022
Ovarian cancer mutational processes drive site-specific immune evasionIgnacio Vázquez-García, Florian Uhlitz, Nicholas Ceglia, et al.
Nature Medicine|January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.
Cancer Cell|March 27, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Pageof 38